All In MedTech

FDA Clearance Tracker · P980035-S483

Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 9, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 9, 2017

Approved

Time to decision

205 days

Received Nov 16, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P980035-S483
Device name
Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)
Applicant location
Mounds View, MN
Received
Nov 16, 2016
Decided
Jun 9, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P980035

Device type

Device class
Class III

Every decision under product code NVZ

FDA's approval statement

As written in FDA's record.

Approval for hardware, firmware, labeling, and manufacturing changes to support replacing the Bluetooth (BT) Classic module with a BT Low Energy module in the monitor base station.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.